Conmed (CNMD) Gross Profit (2010 - 2026)

Conmed (CNMD) has reported Gross Profit for 17 consecutive years, with $197.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Gross Profit rose 4.85% year-over-year to $197.5 million; the trailing twelve-month figure through Jun 2026 stood at $765.3 million (up 2.95% YoY), and the FY2025 full-year result was $750.5 million, up 2.38% from the prior year.
• Gross Profit improved to $197.5 million in Q2 2026 per CNMD's latest filing, from $183.4 million in the prior quarter.
• Across five years, Gross Profit topped out at $218.3 million in Q4 2025 and bottomed at $131.9 million in Q4 2022.
• Historically, Gross Profit has averaged $172.9 million across 5 years, with a median of $174.9 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Gross Profit retreated 15.39% in 2022, then soared 38.16% in 2023.
• Over 5 years, Gross Profit stood at $131.9 million in 2022, then jumped by 38.16% to $182.2 million in 2023, then climbed by 8.88% to $198.3 million in 2024, then gained by 10.05% to $218.3 million in 2025, then decreased by 9.54% to $197.5 million in 2026.
• According to Business Quant data, Gross Profit over the past three periods registered $197.5 million, $183.4 million, and $218.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.